Press Releases

Archive: March 2022

Contract awarded for Phase 1b/2 Huntington's disease trial worth circa £800k

Reflection on IXICO's ability and expertise within the Huntington's disease trials space IXICO plc, the medical imaging advanced analytics company delivering intelligent insights in neuroscience announces that it has been selected by an existing US biotech client to provide PET and MRI neuroimaging services for an open-label Phase I/II dose finding study.

Read more